Avalyn Pharma Inc
4 known investors
Avalyn Pharma develops a nebulized inhalation treatment for pulmonary fibrosis designed to improve tolerability compared to existing oral therapies by directly delivering the drug to the lungs.
BiotechMedical Devices
Founders & leadership
LB
Lyn BaranowskiCEO
Investors · 4
In the news
- Avalyn Pharma closes $345 million IPO on Nasdaq By Investing.cominvesting.com · 2026
- Avalyn Pharma Raises $300 Million in Upsized US IPO Backed by Novo Holdings - Bloombergbloomberg.com · 2026
- Novo-Backed Respiratory Drugmaker Avalyn Pharma Files for US IPOfinance.yahoo.com · 2026
- About | Avalyn Pharma Incavalynpharma.com · 2024
- Avalyn Raises $175 Million in Oversubscribed Series C Financing to Advance Inhaled Pulmonary Fibrosis Programs into Later Stage Clinical Studiesglobenewswire.com · 2023